Insights
Events

Developments in Pharmaceutical and Biotech Patent Law 2016

12/9/2016
San Francisco, CA

Stephanie Skaff to speak at PLI's Developments in Pharmaceutical and Biotech Patent Law 2016 seminar in San Francisco.

Overview

Pharmaceutical and biotech patent law is an important and rapidly changing practice area, and the program is designed to give you the information you need to maintain your practice edge, concentrating on new developments from 2015 and 2016, and placing them in the context of constantly evolving areas of the law.

Technological innovation, Federal Circuit appellate oversight, and Supreme Court decisions continue to drive significant changes in the law. Several different perspectives on many of the most pressing issues will be offered from very experienced practitioners.

Do not miss this opportunity to fully understand the impact of new appellate decisions on your pharmaceutical and biotechnology patent practice.

What You Will Learn

  • Biosimilars: the biosimilar approval process, regulatory exclusivity and patent litigation over biosimilar applications
  • The Supreme Court’s unmaking the law of willfulness: a return patent opinions and uncertainty
  • Continued development of patentable subject matter jurisprudence under Section 101 and an update on USPTO Patentability Guidelines for patentable subject matter
  • Litigating life sciences patent cases in district courts: strategies for fact and expert discovery, effective Markman presentations and technology tutorials, summary judgment and trial
  • Ethical considerations impacting patent practice

Special Feature:

  • Earn One Hour of Ethics Credit

Firm Highlights

Publication

What California’s New Security Law Means to Your Business

Commonsense IoT security steps that startups and small business should consider to comply with California’s new law California recently enacted a new law, Senate Bill 327, that requires companies that make Internet of Things...

Read More
News

Farella Braun + Martel Ranked Among “Best Law Firms” by U.S. News & World Report and Best Lawyers

Read More
News

Jeff Fisher Named Among California’s 2019 Top Trade Secrets Lawyers by the Daily Journal

SAN FRANCISCO, October 9, 2019: Farella Braun + Martel is proud to announce that Jeffrey M. Fisher was named among the “Top Trade Secrets Lawyers” in California by the Daily Journal . Fisher has...

Read More
News

Benchmark California 2020 Ranks Farella Among Top Litigation Firms

Doug Young named among Top 20 Trial Lawyers in California SAN FRANCISCO, October 16, 2019: Farella Braun + Martel continues to be ranked among the top litigation firms by Benchmark California 2020, a guide...

Read More
Publication

Practices to Protect Trade Secrets in Failed Acquisitions and Customer Relationships

Published on  ACCDocket.com . By Walt Norfleet, Smiths Group plc and Eugene Y. Mar, Farella Braun + Martel LLP In part one of this three-part series on best practices for protecting trade secrets and guarding...

Read More
Publication

How Defense Strategies Can Go Awry When Pursuing Concurrent PTAB Relief in Financial Services Patent Litigation

United States Automobile Association (USAA), a financial services company that provides insurance, banking, investment, and retirement products and services for members of the military and their families, filed a surprising patent infringement complaint against Wells Fargo...

Read More
Publication

Securing Against Trade Secret Pitfalls and Dangers Arising From Employee Mobility Situations

Published on ACCDocket.com . By Walt Norfleet, Smiths Group plc and Eugene Y. Mar, Farella Braun + Martel LLP Picture this: Your company is in a highly competitive industry with several leading players heavily supported...

Read More
Publication

Facebook Suspends Apps That Scrape Data From Its Platform Following Cambridge Analytica Scandal

Read More
Publication

Who 'Owns' a Secret? Whether Trade Secret Licensees Have Standing to Sue in California

If the eye-popping damages awards in several recent lawsuits are any indication, companies are increasingly coming to see their private information as one of their most valuable assets—and California juries apparently agree. For example...

Read More